IBD, LLC – Trademark Portfolio

Entity Type: 16

IBD, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CEVAN NUTRITIONALS and A LONG JOURNEY WITH GOD. The owner is based in Wilmington, DE.

37 Springhouse Court

Wilmington, DE 19810

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

IBD, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

40
Treatment & Processing (3 filings)

Treatment of materials

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does IBD, LLC have?

IBD, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 5 cancelled.

What trademark classes does IBD, LLC file in?

IBD, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are IBD, LLC's most well-known trademarks?

IBD, LLC's registered trademark portfolio includes well-known marks such as CEVAN NUTRITIONALS and A LONG JOURNEY WITH GOD. These are among 2 currently registered trademarks in the portfolio.

What is IBD, LLC's trademark registration success rate?

IBD, LLC has a 20% trademark registration rate, with 2 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.